Gitterman Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $125K | Buy |
+3,256
| New | +$125K | 0.03% | 221 |
|
|
2023
Q1 | – | Sell |
-7,529
| Closed | -$265K | – | 94 |
|
|
2022
Q4 | $265K | Sell |
7,529
-18
| -0.2% | -$633 | 0.13% | 42 |
|
|
2022
Q3 | $222K | Buy |
7,547
+27
| +0.4% | +$794 | 0.23% | 51 |
|
|
2022
Q2 | $407K | Sell |
7,520
-183
| -2% | -$9.9K | 0.38% | 29 |
|
|
2022
Q1 | $420K | Buy |
7,703
+3,755
| +95% | +$205K | 0.34% | 36 |
|
|
2021
Q4 | $218K | Buy |
+3,948
| New | +$218K | 0.16% | 78 |
|